Edgewise Therapeutics/$EWTX
About Edgewise Therapeutics
Ticker
Industry
Employees
EWTX Metrics
$2.4B
-
-$1.46
0.15
-
Price and volume
Market cap
$2.4B
Beta
0.15
52-week high
$35.66
52-week low
$9.00
Average daily volume
868K
Financial strength
Current ratio
26.346
Quick ratio
25.982
Long term debt to equity
0.705
Total debt to equity
0.908
Management effectiveness
Return on assets (TTM)
-22.36%
Return on equity (TTM)
-31.90%
Valuation
Price to book
4.89
Price to tangible book (TTM)
4.89
Price to free cash flow (TTM)
-19.539
Growth
Earnings per share change (TTM)
3.69%
3-year earnings per share growth (CAGR)
0.66%
What the Analysts think about EWTX
Analyst Ratings
EWTX Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
EWTX Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
EWTX News
Edgewise: Remains A Buy After Latest Becker Muscular Dystrophy Data
Edgewise Therapeutics' Lead Candidate Reduces Biomarker Levels In Mid-Stage Study In Patients With Muscle Weakness Disease
Edgewise Therapeutics Announces Positive Topline Results from the CANYON Phase 2 Trial of Sevasemten in Individuals with Becker Muscular Dystrophy (Becker)
FAQs
What’s the current market cap for Edgewise Therapeutics stock?
What is the P/E ratio for Edgewise Therapeutics stock?
Does Edgewise Therapeutics stock pay dividends?
No, Edgewise Therapeutics (EWTX) stock does not pay dividends to its shareholders as of January 15, 2025.
When is the next Edgewise Therapeutics dividend payment date?
Edgewise Therapeutics (EWTX) stock does not pay dividends to its shareholders.
What is the beta indicator for Edgewise Therapeutics?
Edgewise Therapeutics (EWTX) has a beta rating of 0.15. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.